The Only Monthly Membership With a Positive ROI!

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Organicell Regenerative Medicine Inc

OCELOTC

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.75

00.00%

At close: Mar 4, 3:51 PM EDT

$1.15

-1.6-58.18%

After Hours: Dec 28, 9:25 AM EDT

15 minutes delayed

Organicell Regenerative Medicine Inc (OCEL) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Organicell Regenerative Medicine Inc (OTC:OCEL) Stock

Organicell Regenerative Medicine Inc Stock (OTC: OCEL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 12, 2023

1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying
Lisa Levin

Monday, July 03, 2023

Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin

Friday, December 09, 2022

Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses
Rachael Green - Sponsored

Monday, November 14, 2022

Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
Ernest Dela Aglanu - Sponsored

Thursday, November 10, 2022

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
Ernest Dela Aglanu - Sponsored

Thursday, October 13, 2022

Organicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of Directors
Kenneth Adams

Friday, September 16, 2022

Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market
Organicell Regenerative Medicine
Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs
Shivani Kumaresan
Organicell Regenerative Medicine Announces Ex...
Benzinga Newsdesk

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved